FDA Invest ApS: Financial statements 2024
CVR: 43586408
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
FDA Invest ApS (CVR 43586408) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,585. Equity in the 2024 report amounted to DKK 36,508. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 3,585
- Equity
- DKK 36,508
- Total Assets
- DKK 36,508
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
FDA Invest ApS has published its interim report for the period October 18, 2022 to December 31, 2023.
About FDA Invest ApS
FDA Invest ApS was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2022. The company has been dissolved on 5 May 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,585. Equity in the 2024 report amounted to DKK 36,508.
